Flecainide and risk of skin neoplasms: results of a large nested case-control study in Spain and Denmark Leggi tutto su Flecainide and risk of skin neoplasms: results of a large nested case-control study in Spain and Denmark
Association between proton pump inhibitor use during early pregnancy and risk of congenital malformations Leggi tutto su Association between proton pump inhibitor use during early pregnancy and risk of congenital malformations
Women on diuretics have a higher risk of hospital admission because of hyponatremia than men Leggi tutto su Women on diuretics have a higher risk of hospital admission because of hyponatremia than men
Two-year outcomes after variable duration of drug cessation in patients with maculopathy associated with pentosan polysulfate use Leggi tutto su Two-year outcomes after variable duration of drug cessation in patients with maculopathy associated with pentosan polysulfate use
Association between antiepileptic drugs and incident Parkinson disease in the UK Biobank Leggi tutto su Association between antiepileptic drugs and incident Parkinson disease in the UK Biobank
Association between sublingual buprenorphine-naloxone exposure and dental disease Leggi tutto su Association between sublingual buprenorphine-naloxone exposure and dental disease
Association of 5α-reductase inhibitors with dementia, depression, and suicide Leggi tutto su Association of 5α-reductase inhibitors with dementia, depression, and suicide
Buprenorphine versus methadone for opioid use disorder in pregnancy Leggi tutto su Buprenorphine versus methadone for opioid use disorder in pregnancy
GLP-1 receptor agonist-associated tumor adverse events: a real-world study from 2004 to 2021 based on FAERS. Front Pharmacol 2022; DOI:10.3389/fphar.2022.925377 Leggi tutto su GLP-1 receptor agonist-associated tumor adverse events: a real-world study from 2004 to 2021 based on FAERS. Front Pharmacol 2022; DOI:10.3389/fphar.2022.925377
Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis Leggi tutto su Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
